FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b) Offers [...]
International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction Many Factors Influence Patient [...]
PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple [...]
The FDA Approves a Generic form of Copaxone® Thursday, April 16, 2015 The U.S. Food and Drug Administration has approved a generic [...]
People with MS may have trouble recognizing emotions -- MS can damage parts of the brain that allow us to recognize emotions in others. [...]
Teva Neuroscience & Access Health Team Up for Special MS Awareness Show: Thursday, March 5 As Multiple Sclerosis Awareness Week [...]
Multiple sclerosis paroxysmal symptoms can be confused with seizures due to its sudden onset. Paroxysmal symptoms are unique to multiple [...]
An international team of researchers have proposed how vitamin D repairs myelin in multiple sclerosis. This finding could lead to [...]
